Biocon to sell 25 percent in arm; plans IPO
Facebook Twitter google+ RSS Feed

Biocon to sell 25 percent in arm; plans IPO

Printer Print Email Email
Bangalore: Biocon will launch an IPO for its fully-owned contract research subsidiary Syngene this financial year, reported Economic Times.

It is learned that the company may offload around 20 to 25 percent of its holding in Syngene as well as make an issue of fresh shares. Biocon registered 29 percent rise in the income from contract research in the fiscal ended March 2008 to Rs 1.76 billion.
Shares of the company gained Rs 4, or 0.79 percent, to end at Rs 508.85. The total volume of shares traded was 1,282,574 at the BSE.

Experts on SiliconIndia
Santhosh  K
Sr. Soft. Engg.
Oracle India
Nehal Vyas
Sr. Team Lead
Cyberoam Tech.
Rani Malli
Sr. Director
Sr. Executive
Vijay Balkrishna Konduskar
Business Consultant
Imans Web Tech
Dr L P  Sharma
Technical Director
Reena Khanna
Dellas  Asse
sys-network admin
Computer Station
Write your comment now
Submit Reset